TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Orifarm Generics AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
62,185
|
52,212
|
43,830 |
| Financial expenses |
66
|
25
|
43 |
| Earnings before taxes |
1,307
|
1,021
|
1,146 |
| EBITDA |
1,244
|
914
|
767 |
| Total assets |
11,272
|
13,547
|
9,942 |
| Current assets |
10,652
|
12,943
|
9,429 |
| Current liabilities |
8,494
|
10,774
|
7,344 |
| Equity capital |
2,778
|
2,774
|
2,598 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
10
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
24.6%
|
20.5%
|
26.1% |
| Turnover per employee |
6,218
|
17,404
|
14,610 |
| Profit as a percentage of turnover |
2.1%
|
2.0%
|
2.6% |
| Return on assets (ROA) |
12.2%
|
7.7%
|
12.0% |
| Current ratio |
125.4%
|
120.1%
|
128.4% |
| Return on equity (ROE) |
47.0%
|
36.8%
|
44.1% |
| Change turnover |
11,748
|
8,254
|
-652 |
| Change turnover % |
23%
|
19%
|
-1% |
| Chg. No. of employees |
7
|
0
|
0 |
| Chg. No. of employees % |
233%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.